P-loop mutations predominated and were not associated with an inferior hematologic or molecular remission rate or shorter remission duration compared with unmutated BCR-ABL.

• 环突变与否，跟临床关系不大，两者相比较，血液学或分子缓解率及缓解持续时间并无差别。